# A Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and Capsules

> **NCT04464187** · — · TERMINATED · sponsor: **AbbVie** · enrollment: 173 (actual)

## Conditions studied

- Endometriosis
- Uterine Fibrioids

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04464187
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-06
- **Primary completion:** 2025-07-11
- **Final completion:** 2025-07-11
- **Target enrollment:** 173 (ACTUAL)
- **Why stopped:** Company Decision
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04464187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04464187, "A Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and Capsules". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04464187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*